4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-24-000009
President and CEO acquired 401,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OConnell Daniel Joseph President and CEO | 2024-01-02 | Grant or award | +401,000 | 517,685 | D | ||
| Derivatives | |||||||
| OConnell Daniel Joseph President and CEO | 2024-01-02 | Grant or award · Employee Stock Option (right to buy) | +602,000 | 602,000 | D | ||
Loading xslF345X05/wk-form4_1704403087.xml…